Elephant in the room? The methodological implications for public health research of performance-enhancing drugs derived from the illicit market.

'All scientific work is incomplete-whether it be observational or experimental. All scientific work is liable to be upset or modified by advancing knowledge. That does not confer upon us a freedom to ignore the knowledge we already have, or to postpone the action that it appears to demand at a given time.'

[1]  H. Geyer,et al.  High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market. , 2007, Biomedical chromatography : BMC.

[2]  A. Nadir,et al.  Cholestatic Jaundice and IgA Nephropathy Induced by OTC Muscle Building Agent Superdrol , 2006, The American Journal of Gastroenterology.

[3]  N. Baume,et al.  Research of stimulants and anabolic steroids in dietary supplements , 2006, Scandinavian journal of medicine & science in sports.

[4]  V. Balan,et al.  Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement. , 2009, Journal of clinical gastroenterology.

[5]  E. Rogers,et al.  Diffusion of innovations , 1964, Encyclopedia of Sport Management.

[6]  P. M. van der Kuy,et al.  Falsification of Thai dianabol. , 1997, Pharmacy World and Science.

[7]  S. Verma,et al.  Hepatotoxicity associated with dietary supplements containing anabolic steroids. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  E Ernst,et al.  Adverse events of herbal food supplements for body weight reduction: systematic review * , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[9]  A. Woolf,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[10]  K. Dietz,et al.  Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. , 2006, Drug and alcohol dependence.

[11]  G. Ferenchick.  Validity of self-report in identifying anabolic steroid use among weightlifters , 1996, Journal of general internal medicine.

[12]  A. Murdoch,et al.  Lesson of the Week: Anabolic steroid abuse by body builders and male subfertility , 1996, BMJ.

[13]  E. Faerstein,et al.  A DICTIONARY OF EPIDEMIOLOGY , 2016 .

[14]  J. Ahmad,et al.  Severe Cholestasis and Renal Failure Associated with the Use of the Designer Steroid Superdrol™ (Methasteron™): A Case Report and Literature Review , 2009, Digestive Diseases and Sciences.

[15]  David Handelsman,et al.  Testosterone: Pharmacology of testosterone preparations , 2004 .

[16]  S. Gordon,et al.  Prolonged Intrahepatic Cholestasis and Renal Failure Secondary to Anabolic Androgenic Steroid-Enriched Dietary Supplements , 2009, Journal of clinical gastroenterology.

[17]  F. Gordon,et al.  Methasteron-associated cholestatic liver injury: clinicopathologic findings in 5 cases. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  N. Benowitz,et al.  Dietary supplement adverse events: Report of a one-year poison center surveillance project , 2008, Journal of Medical Toxicology.

[19]  J. van der Vies,et al.  Comparison of the receptor binding properties of nandrolone and testosterone under in vitro and in vivo conditions. , 1985, Journal of steroid biochemistry.

[20]  H. Geyer,et al.  High doses of the anabolic steroid metandienone found in dietary supplements , 2003 .

[21]  Olubukunola Ayeni,et al.  Epidemiology and Culture , 2008, McGill Journal of Medicine : MJM.

[22]  M. Tóth,et al.  Relative binding affinities of testosterone, 19-nortestosterone and their 5α-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5α-reductive steroid metabolism in the dissociation of “myotropic” and “androgenic” activities of 19-nortestosterone , 1982 .

[23]  David Handelsman,et al.  Androgenic anabolic steroids and arterial structure and function in male bodybuilders. , 2001, Journal of the American College of Cardiology.

[24]  M. Elwood,et al.  Critical Appraisal of Epidemiological Studies and Clinical Trials , 2007 .

[25]  J. Trostle.  Epidemiology and Culture: Cultural Issues in Measurement and Bias , 2005 .

[26]  Douglas G Altman,et al.  [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. , 2007, Gaceta sanitaria.

[27]  J. Baker,et al.  Counterfeiting in performance- and image-enhancing drugs. , 2009, Drug testing and analysis.

[28]  E. Ernst.  Cardiovascular adverse effects of herbal medicines: a systematic review of the recent literature. , 2003, The Canadian journal of cardiology.

[29]  J. McVeigh,et al.  Injecting human growth hormone as a performance-enhancing drug—perspectives from the United Kingdom , 2009 .

[30]  R. Lewontin.  ‘The Selfish Gene’ , 1977, Nature.

[31]  M. Thevis,et al.  Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry , 2008, Journal of sports sciences.

[32]  H. Geyer,et al.  Clenbuterol marketed as dietary supplement. , 2008, Biomedical chromotography.

[33]  S. Sudman,et al.  Validity of drug use reporting in a high-risk community sample: a comparison of cocaine and heroin survey reports with hair tests. , 1999, American journal of epidemiology.

[34]  C. Kochakian,et al.  Anabolic-Androgenic Steroids , 1976, Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology.

[35]  Milos Jenicek,et al.  Clinical Case Reporting in Evidence-based Medicine , 1999 .

[36]  D. Kidwell,et al.  Cocaine detection in a university population by hair analysis and skin swab testing. , 1997, Forensic science international.

[37]  Amer Alghabban,et al.  Dictionary of Pharmacovigilance , 2004 .

[38]  J. Darkes,et al.  Journal of the International Society of Sports Nutrition Open Access a League of Their Own: Demographics, Motivations and Patterns of Use of 1,955 Male Adult Non-medical Anabolic Steroid Users in the United States , 2007 .

[39]  M. Thevis,et al.  Analysis of confiscated black market drugs using chromatographic and mass spectrometric approaches. , 2008, Journal of analytical toxicology.

[40]  N. Evans,et al.  Anabolic androgenic steroids: a survey of 500 users. , 2006, Medicine and science in sports and exercise.

[41]  J. S. Baker,et al.  Steroid and prescription medicine abuse in the health and fitness community: A regional study. , 2006, European journal of internal medicine.

[42]  M. Thevis,et al.  Nutritional supplements cross-contaminated and faked with doping substances. , 2008, Journal of mass spectrometry : JMS.

[43]  J. Vies.  Implications of basic pharmacology in the therapy with esters of nandrolone. , 1985 .

[44]  W. Weinmann,et al.  Anorectic sibutramine detected in a Chinese herbal drug for weight loss. , 2006, Forensic science international.

[45]  M. Shelby,et al.  Detection of bumetanide in an over-the-counter dietary supplement. , 2007, Journal of analytical toxicology.

[46]  Sander Greenland,et al.  Modern Epidemiology 3rd edition , 1986 .